Get notified when TYRA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTyra Biosciences completes routine annual meeting, elects three directors for 2026-2029 term
Filed June 2, 2026 · Period ending May 28, 2026 · ~1 min read
Key Changes
-
low
Three Class II directors elected to three-year terms expiring 2029: Habib J. Dable, Susan Moran M.D., and Robert More, all receiving strong shareholder support with 41-44.5 million votes in favor.
Item 5.07 verify on EDGAR → -
low
Shareholders ratified Ernst & Young LLP as independent auditor for fiscal 2026 with overwhelming approval (53 million votes for, minimal opposition).
Item 5.07 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade TYRA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify